Termination of Protofilament Elongation by Eribulin Induces Lattice Defects that Promote Microtubule Catastrophes-Reference-Cited by-同舟云学术

Termination of Protofilament Elongation by Eribulin Induces Lattice Defects that Promote Microtubule Catastrophes

Published:2016-07 Issue:13 Volume:26 Page:1713-1721
ISSN:0960-9822
Container-title:Current Biology
language:en
Short-container-title:Current Biology

Author:

Doodhi Harinath,Prota Andrea E.,Rodríguez-García Ruddi,Xiao Hui,Custar Daniel W.,Bargsten Katja,Katrukha Eugene A.,Hilbert Manuel,Hua Shasha,Jiang Kai,Grigoriev Ilya,Yang Chia-Ping H.,Cox David,Horwitz Susan Band,Kapitein Lukas C.,Akhmanova Anna,Steinmetz Michel O.

Publisher

Elsevier BV

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology

Reference27 articles.

1. Rapid microtubule self-assembly kinetics;Gardner;Cell,2011

2. Evolving tip structures can explain age-dependent microtubule catastrophe;Coombes;Curr. Biol.,2013

3. Molecular and mechanical causes of microtubule catastrophe and aging;Zakharov;Biophys. J.,2015

4. Microtubule dynamic instability: a new model with coupled GTP hydrolysis and multistep catastrophe;Bowne-Anderson;BioEssays,2013

5. The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth;Jordan;Mol. Cancer Ther.,2005

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads;European Journal of Medicinal Chemistry;2024-10

2. Exploring the potential of thiophene derivatives as dual inhibitors of β-tubulin and Wnt/β-catenin pathways for gastrointestinal cancers in vitro;Heliyon;2024-06

3. Rapid binding to protofilament edge sites facilitates tip tracking of EB1 at growing microtubule plus-ends;eLife;2024-02-22

4. Tubulin inhibitors. Selected scaffolds and main trends in the design of novel anticancer and antiparasitic agents;Bioorganic Chemistry;2024-02

5. Development of tubulin polymerization inhibitors as anticancer agents;Expert Opinion on Therapeutic Patents;2023-11-02